Petra is pleased to announce our latest investment and first deal out of Petra Growth Fund V, Lieberman Research. Petra partnered with Lead Capital Partners, to recapitalize Lieberman and position the company for growth.
Founded in 1981, Lieberman is a premier primary market research and analytics firm serving a diverse client base, with particular expertise in the pharmaceutical, healthcare, and consumer industries. Through direct engagement with physicians, patients, and customers, Lieberman conducts both quantitative and qualitative research. Leveraging proprietary tools and methodologies, the Company delivers tailored insights in areas such as attitude and usage tracking, brand health, brand positioning, competitive intelligence, patient journey mapping, product and pricing strategy, and market segmentation. Lieberman will continue to be led by its existing management team. For more information, please visit liebermanresearch.com.
About Petra Capital Partners
Petra Capital Partners is a private equity firm engaged in providing growth capital for companies located throughout the United States. Our investment team has an established track record of success spanning over 25 years and deploying more than $900 million of capital invested into more than 100 high growth companies. We are seeking investments for our current SBIC fund, Petra Growth Fund V. We can invest up to $25 million per company in equity or debt securities with a primary focus on backing high growth business services, tech-enabled services and healthcare services companies.
To inquire about a new investment opportunity, please contact Carter Owen: cso@petracapital.com
